ImmuCell Corporation Excess Tax Benefit from Share-based Compensation, Financing Activities
ImmuCell Corporation (ICCC) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $78.43 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2021-11-15
- ImmuCell Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2021-09-30 was $78.43K.
- ImmuCell Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2021-06-30 was $102.44K.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month |
|---|---|---|
| 2021-09-30 | $78.43K 10-Q · filed 2021-11-15 | $180.87K derived: sum of 2 quarters · filed 2021-11-15 |
| 2021-06-30 | $102.44K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |